nuclear
factorkappa
b
nfkb
transcript
factor
play
major
role
variou
biolog
process
includ
immun
system
develop
activ
regul
transcript
factor
complex
held
inact
cytoplasm
inhibitor
nfkb
classic
activ
pathway
nfkb
trigger
larg
number
extracellular
stimuli
differ
receptor
result
phosphoryl
kinas
ikk
complex
subsequ
releas
nfkb
complex
transloc
nucleu
drive
target
gene
express
differ
primari
immunodefici
disord
result
genet
defect
involv
compon
link
nfkb
activ
pathway
defici
recent
describ
combin
immunodefici
diseas
lead
impair
nfkb
signal
affect
patient
develop
earli
sever
recurr
infect
caus
bacteri
viral
fungal
mycobacteri
organ
unlik
patient
mutat
patient
typic
ectoderm
dysplasia
inde
patient
defici
describ
literatur
one
patient
ectoderm
dysplasia
form
conic
teeth
herein
describ
clinic
manifest
immunolog
featur
four
saudi
patient
two
relat
famili
diagnosi
combin
immunodefici
due
novel
homozyg
nonsens
mutat
ikbkb
medic
record
four
saudi
patient
two
relat
famili
diagnosi
combin
immunodefici
review
clinic
immunolog
data
collect
autozygos
map
avail
member
whole
exom
sequenc
index
member
perform
previous
describ
written
consent
obtain
parent
studi
approv
research
advisori
council
king
faisal
specialist
hospit
research
center
rac
patient
belong
two
relat
saudi
famili
figur
earli
onset
month
age
sever
infect
caus
virus
bacteria
mycobacteria
fungi
organ
includ
klebsiella
pneumonuia
candida
albican
cmv
bcg
tabl
associ
differ
clinic
manifest
tabl
interestingli
four
patient
delay
umbil
cord
separ
month
display
hypogammaglobulinemia
data
avail
low
absolut
lymphocyt
count
lymphocyt
fail
respond
pha
mitogen
tabl
novel
homozyg
nonsens
mutat
ikbkb
gene
p
figur
c
identifi
patient
within
candid
autozygom
sanger
sequenc
confirm
segreg
diseas
remain
live
sibl
parent
figur
b
three
patient
succumb
diseas
infecti
complic
commenc
hematopoiet
stem
cell
transplant
hsct
patient
underw
hsct
fulli
match
sibl
month
age
save
life
dissemin
bcgiti
receiv
condit
gvhd
prophylaxi
dose
persist
lymphoid
engraft
rang
week
year
hsct
myeloid
engraft
develop
acut
gut
graftvshost
diseas
gvhd
month
hsct
respond
cyclosporin
steroid
treatment
six
month
later
develop
chronic
gut
gvhd
control
medic
although
lymphocyt
subset
prolifer
respons
pha
rel
ratio
show
good
recoveri
clinic
show
good
immun
reconstitut
continu
suffer
dissemin
bcgiti
boni
involv
requir
frequent
surgic
intervent
faciozygomat
osteomyel
year
transplant
still
antimycobacteri
medic
cycloserin
clarithromycin
ethambutol
levofloxacin
monthli
ivig
pentamidin
prophylaxi
last
chimer
test
done
year
posttransplant
show
lymphoid
engraft
myeloid
engraft
sever
dissemin
bcgiti
histori
gvhd
preclud
anoth
trial
transplant
largest
cohort
defici
report
saudi
popul
gener
clinic
featur
patient
differ
previous
report
case
suscept
wide
rang
infect
caus
opportunist
nonopportunist
organ
common
gener
maculopapular
rash
hepatosplenomegali
chorioretin
cn
complic
patient
probabl
relat
chronic
cmv
dissemin
bcg
infect
report
patient
succumb
diseas
infanc
unless
success
hsct
tabl
averag
degre
lymphopenia
profound
patient
compar
other
interestingli
patient
delay
umbil
cord
separ
normal
separ
occur
week
patient
die
infanc
febril
ill
diagnosi
identif
genet
defect
famili
also
report
delay
separ
umbil
cord
none
report
patient
defici
delay
cord
separ
except
one
saudi
arabia
differ
mutat
neutrophil
chemotaxi
adhes
assay
done
patient
delay
cord
separ
report
condit
affect
neutrophil
number
andor
compromis
function
includ
leukocyt
adhes
defect
well
defici
upstream
activ
pathway
featur
may
clue
defici
patient
combin
immunodefici
mechan
ikbkb
mutat
may
predispos
delay
cord
separ
clear
report
neutrophil
infiltr
promin
cord
separ
process
healthi
babi
defect
neutrophil
chemotaxi
adhes
illustr
case
leukocyt
adhes
defici
sinc
defici
patient
literatur
exhibit
delay
cord
separ
except
one
saudi
patient
differ
mutat
like
featur
result
complex
interact
ikbkb
defect
modifi
gene
hand
gainoffunct
gof
mutat
ikbkb
lead
rel
mild
form
combin
immunodefici
ectoderm
dysplasia
immun
dysregul
affect
patient
may
live
fourth
decad
although
diseas
result
hypogammaglobulinemia
lymphopenia
patient
ikbkb
gof
mutat
lower
number
lymphocyt
overactiv
memori
cell
index
patient
unstabl
clinic
condit
dissemin
bcgiti
dictat
decis
noncondit
hsct
fact
sustain
lymphoid
engraft
without
condit
like
due
sever
tcell
dysfunct
type
immunodefici
clear
explan
index
case
clear
dissemin
bcgiti
inspit
recov
vitro
lymphoprolif
respons
pha
one
possibl
donor
cell
anerg
bcg
could
test
far
patient
defici
includ
cohort
undergon
hsct
five
aliv
time
report
receiv
hsct
succumb
diseas
infanc
earli
childhood
survivor
receiv
myeloabl
condit
except
patient
remain
eight
patient
receiv
nonmyeloabl
condit
n
reduc
intens
condit
n
condit
n
although
difficult
draw
conclus
limit
number
report
patient
seem
condit
reduc
intens
condit
suffici
cure
diseas
myeloabl
protocol
need
establish
good
immun
reconstitut
dataset
gener
studi
includ
articlesupplementari
materi
studi
involv
human
particip
review
approv
research
advisori
council
rac
king
faisal
specialist
hospit
research
center
rac
written
inform
consent
particip
studi
provid
particip
legal
guardiannext
kin
author
declar
research
conduct
absenc
commerci
financi
relationship
could
constru
potenti
conflict
interest
review
sp
declar
past
coauthorship
author
ham
handl
editor
